Intercept to Announce First Quarter 2021 Financial Results on May 6, 2021
April 26 2021 - 8:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, will
announce its first quarter 2021 financial results prior to market
open on Thursday, May 6, 2021. The announcement will be followed by
a conference call and audio webcast hosted by Intercept management
at 8:30 a.m. ET to discuss the results.
The conference call will be available on the investor page of
our website at http://ir.interceptpharma.com or by calling (888)
517-2458 (toll-free domestic) or (847) 413-3538 (international)
passcode 9873 994. Archived webcasts will be available on
Intercept’s website for approximately two weeks.
About Intercept
Intercept is a biopharmaceutical company focused on the
development and commercialization of novel therapeutics to treat
progressive non-viral liver diseases, including primary biliary
cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded
in 2002 in New York, Intercept has operations in the United States,
Europe and Canada. For more information, please visit
www.interceptpharma.com or connect with the company on Twitter and
LinkedIn.
CONTACT
For more information about Intercept, please contact:Investor
inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Source: Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2023 to Apr 2024